PO-31: The small-molecule FXIa inhibitor, BMS-26208, prevents tumor cell-induced coagulation activation predominantly in tumor entities with lower tissue factor (TF) expression. Issue 213 (May 2022) - Mäder, J.; Voigtlaender, M.; Rolling, C.; Quick, H.; Schulenkorf, A.; Lehr, C.; Bokemeyer, C.; Beckmann, L.; Langer, F.